Matches in Wikidata for { <http://www.wikidata.org/entity/Q90046790> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q90046790 description "article scientifique publié en 2019" @default.
- Q90046790 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q90046790 description "scientific article published on 01 April 2019" @default.
- Q90046790 description "wetenschappelijk artikel" @default.
- Q90046790 description "наукова стаття, опублікована 1 квітня 2019" @default.
- Q90046790 name "Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors" @default.
- Q90046790 name "Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors" @default.
- Q90046790 type Item @default.
- Q90046790 label "Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors" @default.
- Q90046790 label "Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors" @default.
- Q90046790 prefLabel "Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors" @default.
- Q90046790 prefLabel "Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors" @default.
- Q90046790 P1433 Q90046790-9DE86C4B-20CF-4F0F-AA85-B2B19CB5A035 @default.
- Q90046790 P1476 Q90046790-038A810F-2526-4B83-89BD-206748094FA4 @default.
- Q90046790 P2093 Q90046790-0E2FF663-8B8C-4CF9-AC12-5B77A1316F5E @default.
- Q90046790 P2093 Q90046790-274FCEAB-55E7-4D58-8DBE-8A47CD2499B7 @default.
- Q90046790 P2093 Q90046790-5CEBF4B2-93EB-4371-985B-69F25A850064 @default.
- Q90046790 P2093 Q90046790-94A538A2-F16B-40F3-A750-406B0E34A085 @default.
- Q90046790 P2093 Q90046790-BEA74E37-880B-4D5C-B9FD-2FAA7F088A8F @default.
- Q90046790 P2093 Q90046790-C123FB26-0026-43DC-B844-039ABC7D4832 @default.
- Q90046790 P2093 Q90046790-DC9C3398-4172-4D3C-8E77-F9F10F1A1956 @default.
- Q90046790 P2093 Q90046790-E9A00296-DDD9-4857-9C65-1922EFE07364 @default.
- Q90046790 P2093 Q90046790-F3AD5600-50D2-4CD4-B99F-FC50145737AC @default.
- Q90046790 P2093 Q90046790-F617776F-52E0-48FA-A248-3DC20180436E @default.
- Q90046790 P304 Q90046790-D45E4DAD-9C04-4458-93D8-48187C1F914C @default.
- Q90046790 P31 Q90046790-8504659A-5892-44A8-A7E0-980EEFAA4663 @default.
- Q90046790 P356 Q90046790-59043E5C-48CE-4E14-9917-43546267AC25 @default.
- Q90046790 P478 Q90046790-D1706917-5767-435D-BDE3-EC8D51C29F05 @default.
- Q90046790 P577 Q90046790-F4A3BFDC-0916-425D-999E-400934DA732E @default.
- Q90046790 P921 Q90046790-69916D50-511A-46B6-9BC1-0357C8964887 @default.
- Q90046790 P356 MDZ073.001 @default.
- Q90046790 P1433 Q326122 @default.
- Q90046790 P1476 "Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors" @default.
- Q90046790 P2093 "A Kunert" @default.
- Q90046790 P2093 "A-M C Dingemans" @default.
- Q90046790 P2093 "D Dumoulin" @default.
- Q90046790 P2093 "E F Smit" @default.
- Q90046790 P2093 "H J M Groen" @default.
- Q90046790 P2093 "J G Aerts" @default.
- Q90046790 P2093 "K Bezemer" @default.
- Q90046790 P2093 "M Poncin" @default.
- Q90046790 P2093 "P de Goeje" @default.
- Q90046790 P2093 "R Hendriks" @default.
- Q90046790 P304 "ii7" @default.
- Q90046790 P31 Q13442814 @default.
- Q90046790 P356 "10.1093/ANNONC/MDZ073.001" @default.
- Q90046790 P478 "30 Suppl 2" @default.
- Q90046790 P577 "2019-04-01T00:00:00Z" @default.
- Q90046790 P921 Q413299 @default.